VIRP.PA
Virbac SA
Price:  
350.50 
EUR
Volume:  
4,898.00
France | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

VIRP.PA Relative Valuation

105.2%
Upside

As of 2026-02-07, the Relative Valuation of Virbac SA (VIRP.PA) is 719.29 EUR. This relative valuation is based on P/E multiples. With the latest stock price at 350.50 EUR, the upside of Virbac SA based on Relative Valuation is 105.2%.

The range of the Relative Valuation is 336.12 - 1,331.08 EUR.

Range Selected
Trailing P/E multiples 17.1x - 23.6x 19.4x
Forward P/E multiples 17.6x - 22.8x 18.2x
Fair Price 336.12 - 1,331.08 719.29
Upside -4.1% - 279.8% 105.2%
350.50 EUR
Stock Price
719.29 EUR
Fair Price

VIRP.PA Relative Valuation - Historical P/E Data

Date P/E
2026-02-05 6.27
2026-02-04 6.26
2026-02-03 6.21
2026-02-02 6.24
2026-01-30 6.24
2026-01-29 6.36
2026-01-28 6.48
2026-01-27 6.54
2026-01-26 6.47
2026-01-23 6.46
2026-01-22 6.51
2026-01-21 6.37
2026-01-20 6.52
2026-01-19 6.21
2026-01-16 6.34
2026-01-15 6.39
2026-01-14 6.40
2026-01-13 6.42
2026-01-12 6.37
2026-01-09 6.46
2026-01-08 6.42
2026-01-07 6.38
2026-01-06 6.31
2026-01-05 6.38
2026-01-02 6.28
2025-12-31 6.35
2025-12-30 6.33
2025-12-29 6.36
2025-12-24 6.25
2025-12-23 6.30
2025-12-22 6.22
2025-12-19 6.21
2025-12-18 6.14
2025-12-17 6.15
2025-12-16 6.13
2025-12-15 6.00
2025-12-12 6.02
2025-12-11 6.05
2025-12-10 6.02
2025-12-09 6.06
2025-12-08 6.19
2025-12-05 6.33
2025-12-04 6.32
2025-12-03 6.33
2025-12-02 6.34
2025-12-01 6.42
2025-11-28 6.54
2025-11-27 6.55
2025-11-26 6.44
2025-11-25 6.42